Chen Yunbo, Zhang Guijuan, Chen Xiaoping, Jiang Xuefeng, Bie Fengjie, Yuan Naijun, Wang Yurong, Hao Xiaoqian, Ma Min
College of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, China.
The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong 510630, China.
Evid Based Complement Alternat Med. 2018 Feb 20;2018:4924279. doi: 10.1155/2018/4924279. eCollection 2018.
To investigate the effects of Jianpi Bushen (JPBS), a traditional Chinese medicine that is used to invigorate the spleen and tonify the kidney, combined with chemotherapy for the treatment of gastric cancer. Literature retrieval was performed in PubMed, EMBASE, Cochrane Library, MEDLINE, CNKI, Wanfang Data Information Site, and VIP from inception to October 2017. Randomized controlled trials to evaluate the effects of JPBS combined with chemotherapy were identified. The primary reported outcomes were KPS (Karnofsky Performance Status), clinical curative efficiency, immune function, blood system, and nonhematologic system. Review Manager 5.3 (RevMan 5.3) was used for data analysis, and the quality of the studies was also appraised. A total of 26 studies were included with 3098 individuals. The results of the meta-analysis indicated that treatment of gastric cancer with the combination of JPBS and chemotherapy resulted in better outcomes compared to chemotherapy alone. Evidence from the meta-analysis suggested that JPBS combined with chemotherapy has a positive effect on gastric cancer treatment. However, additional rigorously designed and large sample randomized controlled trials are required to confirm the efficacy and safety of this treatment.
为探讨健脾补肾中药联合化疗治疗胃癌的效果。检索了PubMed、EMBASE、Cochrane图书馆、MEDLINE、中国知网、万方数据信息服务平台和维普资讯,检索时间从建库至2017年10月。纳入评估健脾补肾中药联合化疗效果的随机对照试验。主要报道的结局指标为卡氏功能状态评分(KPS)、临床疗效、免疫功能、血液系统和非血液系统。采用Review Manager 5.3(RevMan 5.3)进行数据分析,并对研究质量进行评价。共纳入26项研究,涉及3098例个体。Meta分析结果表明,与单纯化疗相比,健脾补肾中药联合化疗治疗胃癌的效果更好。Meta分析证据提示,健脾补肾中药联合化疗对胃癌治疗有积极作用。然而,需要更多设计严谨、大样本的随机对照试验来证实该治疗方法的疗效和安全性。